Xentria Inc.

Pulmonary sarcoidosis and systemic inflammatory disease

Clinical research in pulmonary sarcoidosis with or without extrapulmonary manifestations is a major focus, with attention to respiratory involvement and broader inflammatory burden.

  • Immune-mediated granulomatous disease
  • Corticosteroid-sparing therapy
  • Long-term safety and tolerability

Work in this area centers on treatment options for patients with persistent disease activity and associated organ involvement.

Osteoporosis and bone health

The sponsor supports research in postmenopausal osteoporosis, with emphasis on bone preservation and comparative biologic performance in bone mineral density outcomes.

  • Bone remodeling
  • Postmenopausal bone loss
  • Biologic similarity in osteoporosis care

This therapeutic area reflects interest in skeletal fragility and therapies used to reduce fracture-related risk.

Reproductive medicine and functional female infertility

Research also extends to functional female infertility, indicating involvement in reproductive endocrinology and treatments relevant to ovulatory function and fertility support.

  • Female infertility
  • Fertility treatment
  • Reproductive hormone support

These studies align with clinical interest in conditions affecting conception and reproductive capacity.

Healthy volunteer pharmacology

Trials in healthy volunteers support evaluation of pharmacokinetics, pharmacodynamics, and immunogenicity for biologic candidates and comparability studies.

  • Pharmacokinetic similarity
  • Safety and tolerability
  • Biologic characterization

This area underpins development work across immune, endocrine, and bone-related therapeutic programs.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of XTMAB-16 and Prednisolone Sodium Phosphate for Patients with Pulmonary Sarcoidosis

    Recruiting

    1 1 1
    Investigated diseases:
    Czechia Denmark Italy Poland Spain
  • Study on the Effects of XTMAB-16 and Prednisolone in Patients with Pulmonary Sarcoidosis with or without Other Body Involvement

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Czechia Denmark Greece Italy Poland Spain
  • Study on Long-term Safety of XTMAB-16 for Patients with Pulmonary Sarcoidosis with or without Extra-pulmonary Involvement

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark Italy Poland Spain
  • Study Comparing MAB-22 and Denosumab for Treating Osteoporosis in Postmenopausal Women

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Poland